Search Results

Vericel Corporation today announced that it will report its first-quarter 2024 financial results on Wednesday, May 8, 2024.

Vericel Corporation reported financial results and business highlights for the first quarter ended March 31, 2024.

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference at 9:40 a.m. ET on Wednesday, May 29, 2024.

Vericel Corporation today announced that Nick Colangelo, President and CEO will present at the Canaccord Genuity Musculoskeletal Conference.

Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, announced that it will report its fourth-quarter and full-year 2023 financial results on Thursday, February 29, 2024.

Vericel Corporation today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will present at the Stephens Annual Investment Conference.

Vericel Corporation today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference at 11:10 a.m. ET on Tuesday, March 5, 2024.